Lithium and eGFR: a new routinely available tool for the prevention of chronic kidney disease.
about
Managing the risk of lithium-induced nephropathy in the long-term treatment of patients with recurrent affective disordersEvidence-based guidelines for treating bipolar disorder: revised second edition--recommendations from the British Association for Psychopharmacology.The science and practice of lithium therapy.Monitoring lithium therapy: the impact of a quality improvement programme in the UK.Lithium and nephrotoxicity: a literature review of approaches to clinical management and risk stratification
P2860
Lithium and eGFR: a new routinely available tool for the prevention of chronic kidney disease.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Lithium and eGFR: a new routin ...... ion of chronic kidney disease.
@en
Lithium and eGFR: a new routin ...... ion of chronic kidney disease.
@nl
type
label
Lithium and eGFR: a new routin ...... ion of chronic kidney disease.
@en
Lithium and eGFR: a new routin ...... ion of chronic kidney disease.
@nl
prefLabel
Lithium and eGFR: a new routin ...... ion of chronic kidney disease.
@en
Lithium and eGFR: a new routin ...... ion of chronic kidney disease.
@nl
P1476
Lithium and eGFR: a new routin ...... ion of chronic kidney disease.
@en
P2093
Benson Benjamin
Richard Morriss
P356
10.1192/BJP.BP.108.051268
P407
P577
2008-08-01T00:00:00Z